Abstract
Bronchopulmonary dysplasia (BPD) is the most common challenge in preterm neonates. Retardation of alveolar development characterizes the pulmonary pathology in BPD. In the present study, we explored the roles of the CD146-HIF-1α axis in BPD. We demonstrated that the levels of reactive oxygen species (ROS) and soluble CD146 (sCD1146) were increased in the peripheral blood of preterm neonates with BPD. In alveolar epithelial cells, hyperoxia promoted the expression of HIF-1α and CD146, which reinforced each other. In a mouse model of BPD, by exposing pups to 65% hyperoxia, HIF-1α and CD146 were increased in the pulmonary tissues. Mechanistically, CD146 hindered the migration of alveolar epithelial cells; in contrast, movement was significantly enhanced in CD146-knockout alveolar epithelial cells. As expected, CD146-knockout ameliorated alveolarization and improved BPD disease severity. Taken together, our findings imply that the CD146-HIF-1α axis contributes to alveolarization and that CD146 may be a novel candidate in BPD therapy.
Similar content being viewed by others
Introduction
Bronchopulmonary dysplasia (BPD) in preterm neonates is a serious lung condition characterized by the retarded development of alveoli and vasculature1. Previously, we demonstrated that the extracellular matrix (ECM) protein fibronectin was involved in alveolar maturation and therefore contributed to the pathogenesis of BPD2,3. The maturation of alveoli largely depends on the behavior of alveolar epithelial cells, i.e., cell migration4. The ECM provides a scaffold for and guides alveolar epithelial cell migration5. As an adhesion molecule, CD146 regulates the migration of monocytes6 and endothelial cells7,8. In pulmonary epithelial cells, CD146 promotes the adherence of viruses9, bacteria10, and fungi11 to the pulmonary epithelium. However, the roles of CD146 in the migration of alveolar epithelial cells and the maturation of alveoli in the development of BPD are largely elusive.
With oxygen supplementation therapy, reactive oxygen species (ROS) are elevated in preterm infants, which is associated with impaired lung development12. In the endothelia cells, ROS burst induces CD146 dimerization, leading to angiogenesis13. In addition to CD146 dimer, CD146 may be bound with various receptors. Among of them, S100A8/A9 interacting with CD146 promotes the formation of ROS in melanoma cells14, suggesting that ROS and CD146 may be synergistic. Hypoxia-inducible factor 1α (HIF-1α), a pivotal player in the pathogenesis of BPD, may be potentially induced by ROS15. In the immature fetal lung, HIF-1α in the branching epithelium improves lung growth16. In postnatal lung developing, HIF-1α similarly increases vasculature growth and alveolar maturation17. As expected, HIF-1α stabilization preserves alveolar and vascular growth in the BPD model18. In contrast, HIF-1α deficiency reduces lung morphogenesis19. Although HIF-1α is required for lung growth, excessive HIF-1α, as the other side of the same coin, is deleterious to alveolar maturation20, suggesting that balanced production of HIF-1α should be strictly controlled in lung development. In endothelial cells, HIF-1α and CD146 reinforce each other, thereby promoting vasculature development21. Whether HIF-1α and CD146 mediate the epithelial cells migration in the BPD is unknown. In the present study, we aim to explore the hypothesis that HIF-1α and CD146 mediate alveolar epithelial cells migration and contribute to the development of BPD. Our data demonstrate that CD146 stimulated by ROS and HIF-1α suppress the migration of alveolar epithelial cells. CD146 deficiency alleviates the BPD disease severity.
Materials and methods
Preterm infants
Preterm infants born at gestational age ≤32 weeks were admitted to the neonatal intensive care unit at Children’s Hospital of Nanjing Medical University and were enrolled in the study between July 2020 and January 2021. The infants were diagnosed with BPD according to the workshop definition by the National Institutes of Child Health, the Human Development/National Heart, Lung, and Blood Institute and the Office of Rare Diseases22. Preterm infants without BPD were randomly selected for the control group. Infants with severe congenital malformations and inherited metabolic diseases were excluded from the study.
ROS and sCD146 detection in plasma samples
Routine clinical data were collected for all enrolled infants. A total of 1 ml of fasting peripheral venous blood samples was taken and saved in an anticoagulant tube each time. The level of ROS was measured with a microplate reader (Biotek Instruments, Inc., USA) at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. ROS were also captured by an Olympus IX73 inverted microscope at ×200 magnification. All ROS tests were performed in accordance with the manufacturer’s instructions (s0033, Beyotime, China). Soluble CD146 (sCD146) in human plasma was measured using a commercial sCD146 ELISA kit (E-EL-H2403c, Elabscience, China) according to the instructions provided by the manufacturer.
Animals and ethics statement
Wild-type C57BL/6J mice (female and male) at 6–8 weeks of age were obtained from the Laboratory Animal Center of Nanjing Medical University (Nanjing, China) and bred under specific pathogen-free conditions at Nanjing Medical University. CD146-knockout (KO) mice on a C57BL/6J background were obtained from Cyagen, Suzhou, China.
Animal model of BPD
The mouse model of BPD was established as described previously23,24. Briefly, newborn C57BL/6J pups from several litters were mixed and randomly divided into a control group and an experimental group. Then, the control group and the experimental group were exposed to indoor air (21% oxygen) or 65% oxygen within 24 h after birth until the 5th day, when the puppies exposed to oxygen returned to indoor air. The temperature (22 °C) and humidity (50–60%) were kept constant. To avoid oxygen toxicity in the dams and to eliminate maternal effects between groups, the nursing dams were rotated between their hyperoxia and room air litters every 24 h. All mice were maintained on a 12-h light-dark cycle. Mice were euthanized on 14 by the injection of pentobarbital sodium (200 mg/kg i.p.).
To explore the roles of CD146 in BPD pathogenesis, CD146-knockout (CD146 KO) pups were treated with 65% oxygen to establish a BPD model. Wild-type BPD mice was set as the control group.
Lung sample preparation
Mice were sacrificed by intraperitoneal injection of sodium pentobarbital. After aortic transection, a thoracotomy was performed, the right bronchus was ligated, and the right lungs were removed and snap frozen. The tracheas were cannulated, and the left lungs were inflated and fixed with 4% paraformaldehyde (G1101, Servicebio, China) at a pressure of 25 cm H2O for ≥15 min. After equilibration, the left lungs were removed and fixed in 4% formalin overnight. Subsequently, paraffin embedded lung tissues were cut into 5 μm-thick sections on a Leica model 2165 rotary microtome (Leica, Nussloch, Germany) and stained with H&E as previously described25,26.
H&E staining
Tissue sections were stained with hematoxylin and eosin (H&E) for morphometric analyses. To assess uniform and proportional samples from each lung, three nonoverlapping photomicrographs in different sections were captured at ×200 magnification with a microscope (model BX-53, Olympus Optical) under identical lighting conditions and optical settings by an investigator blinded to the grouping. Three images per animal were analyzed and averaged using research-based digital image analysis software (ImageJ, JAVA). The analytical methods of radial alveolar counts (RAC) and mean linear intercept (MLI) were determined by standard morphometric techniques27,28. Briefly, MLI was determined by superimposing a predetermined grid on the image, with set randomly placed lines, and the number of times the lines cross an air–tissue interface counted28. And alveolarization was assessed by standard RAC methods, as previously described29,30. Briefly, respiratory bronchioles were identified as bronchioles lined by epithelium in one part of the wall. From the center of the respiratory bronchiole, a perpendicular line was dropped to the edge of the acinus (connective tissues or septum or pleura), and the number of septae intersected by this line was counted.
Immunohistochemical staining
In the fixed lung tissues, 5-μm sections were cut and deparaffinized. Antigen retrieval was performed in 10 mM citrate buffer, pH 6.0, in a pressure cooker for 10 min. Endogenous peroxidase activity was inhibited using a 3% H2O2 solution applied to the slides for 15 min, followed by a 30-min blocking step using 3% BSA in PBS. The slides were then incubated with rabbit polyclonal HIF-1α antibody (1:100, Servicebio, China) or rabbit monoclonal CD146 (1:200, ab75769, USA) for 1 h at room temperature. The slides were further stained with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (EarthOx Life Sciences, CA, USA) for 50 min at room temperature. Then, freshly prepared DAB chromogenic reagent was added to mark the tissues. Finally, the sections were counterstained with hematoxylin staining solution and captured at ×400 magnification with a microscope (model BX-53, Olympus Optical).
Lung mechanics
As previously described31, the mouse trachea was exposed and connected to a computer-controlled small animal mechanical ventilator (flexiVent, SCIREQ). After two recruitment breathes of sustained inspiration up to a pressure of 30 cm H2O for 3 s, saline control and methacholine at 3.125, 6.25, 12.5, 25, 50, and 100 mg/ml (Sigma Aldrich) were aerosolized using an ultrasonic nebulizer diverted into the ventilator’s inspiratory flow over 10 s. Measurements of average respiratory system resistance (Rrs) and compliance (Crs) were made every 40 s over 5 min after each dose.
Cell culture
Primary alveolar epithelial cells from mice were purified using 0.1% collagenase, 0.25% trypsin, and DNase I and were selected with mouse IgG (36111ES60, Yeasen, China) as previously described32. The MLE-12 cell line was obtained from ATCC (CRL-2110, USA) and cultured according to the protocol provided by ATCC. MLE-12 cells were cultured in DMEM (HyClone, USA) with 10% fetal bovine serum (Lonsera, USA) and 1% penicillin/streptomycin (HyClone, USA) in a humidified atmosphere of 5% CO2 at 37 °C overnight. MLE-12 cells were treated with 0, 50, 100, 250, or 500 μmol/l H2O2 or an equal volume of DMEM (HyClone, USA) as a control. When needed, the PI3K inhibitor LY294002 (MCE, USA, HY-10108) or ERK inhibitor U0126 (MCE, USA, HY-1203) was added to the medium at a final concentration of 10 µM. Cells were harvested 12 h later for further analysis.
Cell transfection
MLE-12 cells were seeded and incubated overnight before transfection. After mixing with Liposomal Transfection Reagent (Yeasen, China) in DMEM without FBS, penicillin or streptomycin for 25 min, the expression plasmid encoding CD146 or HIF-1α (Abmgood, China) was then transfected into MLE-12 cells at 90–95% density in DMEM for 48 h. The cells were harvested for further analysis. The blank vehicle plasmid was set as a control.
RNA isolation and quantitative real-time PCR
Total RNA was obtained from fresh lung tissue with a TRIzol reagent kit (Life Technologies) and reverse transcribed into cDNA with a reverse transcription kit (Abmgood, Zhenjiang, China) according to the manufacturer’s instructions. HIF-1α, CD146, and β-actin mRNA expression was quantified with a StepOnePlus Real-Time PCR System (ABI, USA). The primers used for real-time PCR were designed by referring to PrimerBank (https://pga.mgh.harvard.edu/primerbank). Primers with the following sequences were used: CD146 forward, 5-GGAAAATCAGTATCTGCCTCTCC-3; CD146 reverse, 5-GGAAAATCAGTATCTGCCTCTCC-3; HIF-1α forward, 5-ACCTTCATCGGAAACTCCAAAG-3; HIF-1α reverse, 5-CTGTTAGGCTGGGAAAAGTTAGG-3; β-actin forward, 5- GGCTGTATTCCCCTCCATCG-3; and β-actin reverse, 5-CCAGTTGGTAACAATGCCATGT-3. Relative levels were determined using the comparative CT method, and β-actin was used as the internal control33. Each sample was run in triplicate, and the results are representative of at least three independent experiments.
Protein extraction and western blotting
Total protein was extracted from cells or tissues by lysis with RIPA buffer containing protease and phosphatase inhibitor cocktails (Beyotime, Shanghai, China) and sonicated on ice 3 times for 20 s each time. Protein concentrations were determined with a bicinchoninic acid (BCA) assay. Equal amounts of proteins were used for SDS–PAGE. The proteins were separated by 10% SDS–PAGE and transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, USA). The membranes were blocked for 1 h in 5% skim milk at room temperature and incubated at 4 °C overnight with the following primary antibodies: anti-CD146 (ab75769, Abcam), anti-HIF-1α (ab54385, Abcam), anti-Erk (4695, Cell Signaling Technology), anti-p-Erk (4370, Cell Signaling Technology), anti-Akt (4691, Cell Signaling Technology), anti-p-Akt (4060, Cell Signaling Technology) and anti-β-actin (4970L, Cell Signaling Technology). The membranes were then washed three times with Tris-buffered saline Tween-20 (TBST) and incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (EarthOx Life Sciences, CA, USA) or goat anti-mouse IgG (H + L) HRP (s0002, Affinity Biosciences) for 1 h at room temperature. β-actin was used as an internal control. The antibody–antigen complexes were detected with Immobilon Western Chemiluminescent HRP Substrate (Millipore, MA, USA) and visualized using the G:Box gel doc system (Syngene, UK).
Cell scratch test
When the cells seeded in 6-well plates reached a confluent state, a single scratch was made using a sterile yellow pipette tip. MlE-12 cells with normal or overexpression of CD146 were then incubated with FBS-free culture medium (to exclude the potential effects of FBS on cell migration) alone. Images of the scratches were captured at 0, 6, 12, and 24 h with an Olympus IX73 inverted microscope at ×200 magnification. The wound area was examined by the wound margin and calculated using ImageJ34. Cell mobility = (scratch width at 0 h − scratch width after culture)/scratch width at 0 h × 100%.
Transwell migration assay
Transwell migration assays were performed using Transwell inserts (Corning Costar, USA) with a filter of 6.5 μm pores. Primary alveolar epithelial cells (WT or CD146 KO) were obtained according to a previous method32. A total of 1 × 104 cells in serum-free medium were seeded into the upper chamber of the insert, and complete medium was added to the lower chamber. After 24 h of incubation, the cells were fixed with 4% paraformaldehyde (G1101, Servicebio, China) and stained with Giemsa. Then, cells on the top surface of the membrane were wiped off, and cells on the lower surface were examined under an Olympus BX-53 microscope at ×200 magnification. Five random fields were photographed for counting purposes, and the average number of migrated cells was used as a measure of migration capacity.
Live-cell imaging technique
Primary alveolar epithelial cells (1 × 103/ml, WT or CD146 KO) were seeded onto a 96-well cell culture plate and treated with complete medium. Then, the 96-well cell culture plate was transferred into the temperature- and CO2-controlled (37 °C, 5% CO2) environment of a Zeiss Cell Discoverer microscope system. Live-cell phase-gradient contrast images of the individual field regions inside each well were automatically acquired using ZEN Blue 2.3 software. Representative figure images were selected, and additional image postprocessing steps were performed in ImageJ.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 8.0 software. Values are expressed as the means ± SDs. Differences between the groups were assessed by one-way analysis of variance and the Student–Newman–Keuls test (for multiple comparisons). Statistical significance was defined as follows: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, and NS, not significant.
Results
Increased ROS and sCD146 in peripheral blood from BPD infants
In preterm infants, supplemental oxygen is frequently needed, which adds to the risk of oxidant injury35. Accordingly, to investigate the effects of oxidant injury on preterm infants, we recruited 19 preterm infants, including 9 BPD infants and 10 non-BPD control neonates (Table 1). Compared with the control group, ROS levels in the peripheral blood from BPD infants were significantly increased (Fig. 1A, B). Additionally, we found that plasma sCD146 was concurrently increased in BPD neonates (Fig. 1C). In sum, ROS and CD146 were increased in preterm neonates with BPD, which may play important roles in the pathogenesis of BPD.
ROS directly induced HIF-1α expression in epithelial cells
Hyperoxia can lead to excessive production of ROS36, which not only promotes the transcription of HIF-1α37 but also maintains the stability of HIF-1α38. To simulate hyperoxia-induced lung injury, alveolar epithelial cells were treated with H2O2. As shown in Fig. 2A, B, H2O2 induced the expression of HIF-1α in epithelial cells. Previous studies have shown that the ERK pathway and PI3K pathway play important roles in ROS-induced HIF-1α expression39,40,41. Unsurprisingly, H2O2 activated the ERK and PI3K/Akt pathways in alveolar epithelial cells (Fig. 2C). Furthermore, inhibitors of ERK (U0126) and PI3K (LY294002) rescued the expression of HIF-1α in epithelial cells treated with H2O2 (Fig. 2D, E). Overall, these results indicated that H2O2 directly promoted the expression of HIF-1α in lung epithelial cells through the ERK and PI3K/Akt pathways.
Hyperoxia-induced HIF-1α and CD146 expression in epithelial cells
To better simulate oxygen-induced lung injury in the clinic, we directly treated lung epithelial cells with hyperoxia (65% oxygen). At the gene level, 65% hyperoxia significantly increased HIF-1α in alveolar epithelial cells at 24 h (Fig. 3A), but CD146 expression was upregulated until 72 h post hyperoxia (Fig. 3B). Similarly, the protein levels of CD146 and HIF-1α in alveolar epithelial cells were significantly increased after 72 h of stimulation with 65% oxygen (Fig. 3C). Together, these results indicated that hyperoxia directly induced the expression of HIF-1α and CD146 in alveolar epithelial cells.
Positive feedback of HIF-1α and CD146 in epithelial cells
Thus far, we demonstrated that ROS and sCD146 were increased in BPD patients and that ROS promoted HIF-1α expression. Therefore, we further explored the potential relationships between HIF-1α and CD146. As shown in Fig. 4A, SPC-positive alveolar epithelial cells co-expressed CD146. We then overexpressed HIF-1α in the alveolar epithelial cell line MLE-12. Accompanied by HIF-1α elevation, CD146 was significantly increased (Fig. 4B). This result was consistent with previous studies showing that HIF-1α binding to CD146 hypoxia response element (HRE) promoted CD146 transcription42.
Given that CD146 promoted the expression of NF-κB (P65)43,44 and P65 regulated HIF-1α expression45, we hypothesized that CD146 may be involved in the regulation of HIF-1α expression. To explore this, we overexpressed CD146 in MLE-12 cells and found that HIF-1α was upregulated in CD146-overexpressing epithelial cells (Fig. 4C, D). Similarly, the expression of pP65/P65 and HIF-1α was notably decreased after CD146 knockout (Fig. 4E). In short, these results suggested that the CD146-HIF-1α axis formed a positive feedback loop in alveolar epithelial cells.
Increased pulmonary HIF-1α and CD146 in a mouse model of BPD
To demonstrate the significance of the CD146-HIF-1α axis in BPD, we established a murine model of BPD with postnatal hyperoxia. As depicted in Fig. 5A, pups were exposed to either indoor air (21% oxygen, control group) or 65% oxygen (BPD group) until the 5th day. The hyperoxia-treated mice weighed an average of 16.2% less at P14 than the control mice reared under normoxic conditions (Fig. 5B), as reported in a previous publication46. Compared with the control group, histological analysis demonstrated arrested alveolar development, with a significantly decreased number of large, simplified alveoli in the BPD group. In contrast, the mean linear intercept in the BPD group was significantly increased (Fig. 5C–E). In addition, the BPD group also showed notably increased respiratory resistance (Rrs) and decreased compliance resistance (Crs) (Fig. 5F). After inhalation of acetylcholine, the BPD group displayed significantly increased Rrs and slightly decreased Crs (Fig. 5G).
To explore whether the CD146-HIF1-α axis was involved in the pathogenesis of BPD, we measured the expression of CD146 and HIF-1α in pulmonary tissues using PCR and Western blot, and both HIF-1α and CD146 were significantly higher in the BPD group than in the control group (Fig. 5H–J). Moreover, immunohistochemistry assays (Fig. 5K) validated that CD146 was more pronounced in the BPD group. Collectively, these results implied that the CD146-HIF-1α axis was notably important at the early stage of BPD disease.
CD146 decelerated the alveolar epithelial cells
Preterm infants with BPD display deficits in alveolarization, cellular migration, and injury repair47,48. CD146 regulates cell migration in a variety of ways. CD146 inhibits migration in activated T cells49 and trophoblast cells50 but promotes migration in tumors51 and endothelial cells7. We hypothesized that CD146 may regulate alveolar epithelial cell migration and thereby participate in BPD pathogenesis. To assess this, a scratch wound migration assay, Transwell chamber migration assay, and live-cell imaging were performed. In the scratch wound migration assay (Fig. 6A), the migration distance of epithelial cells that had been transfected with CD146 was significantly reduced compared with that of the controls. Conversely, the migration number of CD146-knockout alveolar epithelial cells was notably increased compared with that of the controls in the Transwell chamber migration assay (Fig. 6B). Similarly, time-lapse imaging showed that the velocity of CD146-knockout alveolar epithelial cells was significantly increased compared with that of the WT controls (Fig. 6C–E). Together, these results suggested that CD146 decelerated alveolar epithelial cells; CD146 deficiency promoted the maturation of alveoli in the developing lung and therefore may ameliorate the severity of BPD.
CD146 deficiency relieved disease severity of BPD
To provide direct genetic evidence that disrupting the CD146-HIF-1α axis may affect BPD development, we established a mouse model of BPD using CD146-knockout mice. As shown in Fig. 7A–C, histological analysis on day 14 post birth showed that CD146 deficiency improved alveolar development, with a significantly increased number of alveoli. Conversely, the mean linear intercept was remarkably diminished in CD146-deficient BPD-like mice. Similarly, CD146-deficient BPD-like mice showed notably decreased Rrs and increased Crs (Fig. 7D). After inhalation of acetylcholine, the CD146-deficient BPD-like mice also displayed a significant reduction in Rrs and an increase in Crs (Fig. 7E). Using Western blot assays (Fig. 7F) and immunohistochemistry (Fig. 7G), we discovered that HIF-1α was significantly lower in CD146-deficient BPD-like mice than in wild-type BPD-like mice at 14 days after birth. Collectively, these results implied that CD146 deficiency disrupting the CD146-HIF-1α axis at least partially alleviated BPD disease severity.
Discussion
Despite escalating efforts in prevention, BPD incidence in preterm infants (<28 weeks gestational age) remains stable at 43%52. Retardation and simplification of lung alveolarization are the key histopathological characteristics in preterm infants with BPD. In the term mouse model of BPD53, lung development in pups (E17.5–PN5) resembled that in preterm infants (24–38 weeks gestational age). In the present study, we validated that ROS were elevated in the peripheral blood of BPD infants. Furthermore, in alveolar epithelial cells, hyperoxia increased HIF-1α and CD146, which reciprocally promoted each other. In a mouse model of BPD stimulated with 65% oxygen, HIF-1α and CD146 in the lung tissues were increased. CD146 deficiency promoted alveolar maturation and lung development; therefore, CD146 deficiency ameliorated the disease severity of BPD. RAC and MLI, the most used markers for lung morphometry in the BPD study54,55, were increased in the CD146 defective BPD-like mice. Of note, RAC and MLI may be biased; and the gold standard of lung morphometry is design-based stereology56. Nevertheless, lung functions (Rrs, Crs) were assayed in the present study, which to some extent overcome the pitfalls of RAC and MLI in the lung morphometry. Mechanistically, CD146 decreased the migration of alveolar epithelial cells, and CD146 deficiency, as expected, increased the migration of alveolar epithelial cells.
In line with a previous report that ROS levels were higher in the BPD group57, we evidenced that ROS levels in peripheral blood cells and plasma were higher in preterm neonates with BPD. Either H2O2 or 65% oxygen in the epithelial cell culture system simulated elevated ROS in BPD patients. As expected, H2O2 or 65% oxygen increased HIF-1α and CD146, which was at least partially dependent on the Erk and PI3K/Akt pathways. In pulmonary artery smooth muscle cells, HIF-1α and CD146 reinforce each other58. Similarly, the positive feedback loop of HIF-1α and CD146 was observed in alveolar epithelial cells. ROS increased HIF-1α, which subsequently promoted the expression of CD146 in epithelial cells. CD146 may activate the NF-κB signaling pathway, leading to the elevation of HIF-1α. Disruption of the HIF-1α and CD146 axes in CD146-deficient mice alleviated the disease severity of pulmonary arterial hypertension58. In a mouse model of BPD, CD146 deficiency mitigated the arrest of lung development. The vasculature system is vital in lung maturation. Pulmonary arterial hypertension is a serious complication of BPD59. Therefore, we could not preclude the possibility that the improved vascular remodeling in CD146-deficient mice may promote lung development and therefore provide relief from BPD.
Nonetheless, alveolar arrest is the key characteristic in BPD pathogenesis. In the preterm neonates with immature lung, oxygen therapy is a two-edged sword60. Airway epithelia cells exposed to oxygen and ROS may be damaged. In the alveoli, type 2 alveolar epithelial cells (AT2) rapidly migrate to the wound area and differentiate into type 1 alveolar epithelial cells (AT1)61. AT2 migration is regulated by various factors. Fibronectin in the ECM and its associated intergin directed the migration of alveolar epithelial cells62. The non-receptor tyrosine kinase focal adhesion kinase-1 (FAK) and the chemokine receptor CXCR4 also regulate the migration of alveolar epithelial cells in lung injury63. CD146 is a multifunctional molecule64. As in activated T cells49 and trophoblast cells50, CD146 suppressed migration in alveolar epithelial cells. Therefore, increased CD146 in the pulmonary tissues from BPD-like mice caused arrested alveolarization, and CD146 deficiency improved lung growth in BPD-like mice. CD146 may be a potential candidate in BPD therapy.
Data availability
The data that support the findings of this study are available on request from the corresponding author upon reasonable request.
References
Mathew, R. Signaling pathways involved in the development of bronchopulmonary dysplasia and pulmonary hypertension. Children 7, 100–118 (2020).
Jin, R. et al. IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia. Cell Death Discov. 6, 33 (2020).
Xu, J. et al. Neutrophil extracellular traps degrade fibronectin in a rat model of bronchopulmonary dysplasia induced by perinatal exposure to lipopolysaccharide. J. Cell Mol. Med. 24, 14645–14649 (2020).
Whitsett, J. A. & Weaver, T. E. Alveolar development and disease. Am. J. Respir. Cell Mol. Biol. 53, 1–7 (2015).
Mizikova, I. & Morty, R. E. The extracellular matrix in bronchopulmonary dysplasia: target and source. Front. Med. 2, 91 (2015).
Bardin, N. et al. CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 29, 746–753 (2009).
Kang, Y. et al. Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res. 16, 313–318 (2006).
Zhang, Z., Zheng, Y., Wang, H., Zhou, Y. & Tai, G. CD146 interacts with galectin-3 to mediate endothelial cell migration. FEBS Lett. 592, 1817–1828 (2018).
Berman, R. et al. MUC18 Regulates Lung Rhinovirus Infection and Inflammation. PLoS ONE 11, e0163927 (2016).
Simon, G. C. et al. Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherence. Am. J. Respir. Cell Mol. Biol. 44, 606–613 (2011).
Sun, Z. et al. Fine particulate matter (PM2.5) promotes CD146 expression in alveolar epithelial cells and cryptococcus neoformans pulmonary infection. Front. Microbiol. 11, 525976 (2020).
Wang, J. & Dong, W. Oxidative stress and bronchopulmonary dysplasia. Gene 678, 177–183 (2018).
Zhuang, J. et al. NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. Free. Radic. Biol. Med. 49, 227–236 (2010).
Ruma, I. M. et al. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-kappaB and ROS formation upon ligand binding. Clin. Exp. Metastasis 33, 609–627 (2016).
Wang, G. et al. ROS mediated EGFR/MEK/ERK/HIF-1alpha loop regulates glucose metabolism in pancreatic cancer. Biochem. Biophys. Res. Commun. 500, 873–878 (2018).
Shimoda, L. A. & Semenza, G. L. HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am. J. Respir. Crit. Care Med. 183, 152–156 (2011).
Tibboel, J. et al. Hypoxia-inducible factor-1 stimulates postnatal lung development but does not prevent O2-induced alveolar injury. Am. J. Respir. Cell Mol. Biol. 52, 448–458 (2015).
Wang, J. et al. Effect of intermittent hypoxia or hyperoxia on lung development in preterm rat neonates during constant oxygen therapy. J. Cell Biochem. 120, 17545–17554 (2019).
van Tuyl, M. et al. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L167–L178 (2005).
Bridges, J. P., Lin, S., Ikegami, M. & Shannon, J. M. Conditional hypoxia inducible factor-1alpha induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesis. Dev. Biol. 362, 24–41 (2012).
Luo, Y. et al. CD146-HIF-1alpha hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nat. Commun. 10, 3551 (2019).
Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723–1729 (2001).
Willis, G. R. et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am. J. Respir. Crit. Care Med. 197, 104–116 (2018).
Zhang, Y., Dong, X. & Lingappan, K. Role of HIF-1α-miR30a-Snai1 axis in neonatal hyperoxic lung injury. Oxid. Med. Cell. Longev. 2019, 8327486 (2019).
Park, M. S. et al. Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen. Pediatr. Res. 62, 652–657 (2007).
Rogers, L. K., Tipple, T. E., Nelin, L. D. & Welty, S. E. Differential responses in the lungs of newborn mouse pups exposed to 85% or >95% oxygen. Pediatr. Res. 65, 33–38 (2009).
Cooney, T. P. & Thurlbeck, W. M. The radial alveolar count method of Emery and Mithal: a reappraisal 1—postnatal lung growth. Thorax 37, 572–579 (1982).
Li, H., Yuan, X., Tang, J. & Zhang, Y. Lipopolysaccharide disrupts the directional persistence of alveolar myofibroblast migration through EGF receptor. Am. J. Physiol. Lung Cell Mol. Physiol. 302, L569–L579 (2012).
Tang, J. R. et al. Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin. Am. J. Physiol. Lung Cell Mol. Physiol. 299, L735–L748 (2010).
Wallace, B. et al. Anti-sFlt-1 therapy preserves lung alveolar and vascular growth in antenatal models of bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 197, 776–787 (2018).
Raffay, T. et al. Repeated β2-adrenergic receptor agonist therapy attenuates the response to rescue bronchodilation in a hyperoxic newborn mouse model. Neonatology 106, 126–132 (2014).
Nabhan, A. N., Brownfield, D. G., Harbury, P. B., Krasnow, M. A. & Desai, T. J. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. Science 359, 1118–1123 (2018).
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408 (2001).
Filidou, E. et al. Cytokine receptor profiling in human colonic subepithelial myofibroblasts: a differential effect of Th polarization-associated cytokines in intestinal fibrosis. Inflamm. Bowel Dis. 24, 2224–2241 (2018).
Kapadia, V., Rabi, Y. & Oei, J. L. The Goldilocks principle. Oxygen in the delivery room: when is it too little, too much, and just right? Semin. Fetal Neonatal Med. 23, 347–354 (2018).
Resseguie, E. A., Staversky, R. J., Brookes, P. S. & O’Reilly, M. A. Hyperoxia activates ATM independent from mitochondrial ROS and dysfunction. Redox Biol. 5, 176–185 (2015).
Sasabe, E., Yang, Z., Ohno, S. & Yamamoto, T. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells. Free Radic. Biol. Med. 48, 1321–1329 (2010).
Guzy, R. D. et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401–408 (2005).
de Lemos, M. L. et al. Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models. Int. J. Biochem. Cell Biol. 45, 1377–1388 (2013).
Du, J. et al. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells. PLoS ONE 6, e25213 (2011).
Koshikawa, N., Hayashi, J., Nakagawara, A. & Takenaga, K. Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J. Biol. Chem. 284, 33185–33194 (2009).
Luo, Y. et al. CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nat. Commun. 10, 3551 (2019).
Bu, P. et al. Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation. Mol. Cancer Ther. 5, 2872–2878 (2006).
Ruma, I. M. et al. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Clin. Exp. Metastasis 33, 609–627 (2016).
van Uden, P., Kenneth, N. S. & Rocha, S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem. J. 412, 477–484 (2008).
Chen, H. J. & Chiang, B. L. Effect of hyperoxia on retinoid metabolism and retinoid receptor expression in the lungs of newborn mice. PLoS ONE 10, e0140343 (2015).
Ali, M., Heyob, K., Tipple, T. E., Pryhuber, G. S. & Rogers, L. K. Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD. Respir. Res. 19, 229 (2018).
Ramani, M., Bradley, W. E., Dell’Italia, L. J. & Ambalavanan, N. Early exposure to hyperoxia or hypoxia adversely impacts cardiopulmonary development. Am. J. Respir. Cell Mol. Biol. 52, 594–602 (2015).
Guezguez, B. et al. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J. Immunol. 179, 6673–6685 (2007).
Shih, I., Wang, T., Wu, T., Kurman, R. J. & Gearhart, J. D. Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J. Cell Sci. 111(Pt 17), 2655–2664 (1998).
Luo, Y. et al. Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration. Oncogene 31, 306–321 (2012).
Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314, 1039–1051 (2015).
Berger, J. & Bhandari, V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am. J. Physiol. Lung Cell Mol. Physiol. 307, L936–L947 (2014).
Genschmer, K. R. et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung. Cell 176, 113–26 e15 (2019).
Hirsch, K. et al. Perinatal hypoxia-inducible factor stabilization preserves lung alveolar and vascular growth in experimental bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 202, 1146–1158 (2020).
Giusto, K., Wanczyk, H., Jensen, T., Finck, C. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies. Dis. Model Mech. 14, 1–19 (2021).
Dong, W. et al. Role of the SENP1-SIRT1 pathway in hyperoxia-induced alveolar epithelial cell injury. Free Rad. Biol. Med. 173, 142–150 (2021).
Luo, Y. et al. CD146-HIF-1alpha hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nat. Commun. 10, 3551 (2019).
Bui, C. B. et al. Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants. J. Reprod. Immunol. 124, 21–29 (2017).
Perrone, S., Bracciali, C., Di Virgilio, N. & Buonocore, G. Oxygen use in neonatal care: a two-edged sword. Front. Pediatr. 4, 143 (2016).
Whitsett, J. A., Kalin, T. V., Xu, Y. & Kalinichenko, V. V. Building and regenerating the lung cell by cell. Physiol. Rev. 99, 513–554 (2019).
Kim, H. J., Henke, C. A., Savik, S. K. & Ingbar, D. H. Integrin mediation of alveolar epithelial cell migration on fibronectin and type I collagen. Am. J. Physiol. 273, L134–L141 (1997).
Ghosh, M. C. et al. A heteromeric molecular complex regulates the migration of lung alveolar epithelial cells during wound healing. Sci. Rep. 7, 2155 (2017).
Wang, Z. & Yan, X. CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 330, 150–162 (2013).
Funding
This study was supported by the Women and Children Health Program from Jiangsu Province (FYX202028), Top Talent Support Program for young and middle-aged people of Wuxi Health Committee (BJ2020089), Jiangsu Commission of Health Program (F2020202) and the National Natural Science Foundation of China (82171705, 82171738, and 81671563).
Author information
Authors and Affiliations
Contributions
M.Zhang and R.C. conceived and designed the study. R.J., Q.G., C.Y., M.Zhou, and K.L. performed the experiments. R.J., Q.G., and W.L. drafted the paper. Y.Z., M.Zhang, and R,C, critically revised the paper. All authors read and approved the final version of the paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The study involving human participants were reviewed and approved by ethics committee of Nanjing Children’s Hospital Affiliated to Nanjing Medical University (202111121-1). And all animal protocols were reviewed and approved by the Animal Care and Use Committee of Nanjing Medical University (1910018).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jin, R., Gao, Q., Yin, C. et al. The CD146-HIF-1α axis regulates epithelial cell migration and alveolar maturation in a mouse model of bronchopulmonary dysplasia. Lab Invest 102, 794–804 (2022). https://doi.org/10.1038/s41374-022-00773-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41374-022-00773-z
This article is cited by
-
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Inflammation and Regeneration (2024)